Co-Dafalgan, Brausetabletten

7680473530254 CH-47353 Brausetabletten
Co-Dafalgan, Brausetabletten
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
16
Selling units
16
Measure
Tablette(n)
Galenic form
Brausetabletten
Galenic group
Brausetabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/04/2026
Patient information leaflet
Français
09/04/2026
Patient information leaflet
Italien
09/04/2026
Summary of Product Characteristics
Allemand
09/04/2026
Summary of Product Characteristics
Français
09/04/2026
Summary of Product Characteristics
Italien
09/04/2026

Detailed composition

Substance Quantity Type Category
paracetamolum
500.0 MG Substance Wirkstoff (Principe actif)
codeini phosphas hemihydricus
30.0 MG Substance Wirkstoff (Principe actif)
natrii hydrogenocarbonas
- Substance HNIDK
natrii carbonas
- Substance HNIDK
acidum citricum
- Substance HNIDK
natrii docusas
- Substance HNIDK
povidonum
- Substance HNIDK
aromatica
- Substance AROMA
sorbitolum
300.0 MG Substance HBESI
aspartamum
30.0 MG Substance HBESI
E 211
58.5 MG Substance HBESI
natrium
384.7 MG Substance HBESI

Reimbursement information

Public price
CHF 11.95
Specialties list
Yes
Generic
No
SL addition date: 15/03/1987

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
47353
Drug name
Co-Dafalgan, Brausetabletten
Galenic form
BRAT
ATC Code
N02AJ06
Authorization status
Z
Dispensing category
B
First authorization
03/12/1986
Authorization expiration date
31/12/9999
IT Number
01.01.2.
Domain
Human medicine
Field of application
Analgetikum

Package details

Description (FR)
CO-DAFALGAN cpr eff 500/30mg 16 pce
Description (DE)
CO-DAFALGAN Brausetabl 500/30mg 16 Stk
Market launch
03/12/1986
Narcotic (BTM)
C
Buy us a coffee Explore the data